Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD)

Alternative Medicine Review

Volumn 16, Issue 4, 2011, Pages 323-337

  Pellow, Janice ^a   Solomon, Elizabeth M ^a   Barnard, Candice N ^b  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

^b NONE

Author keywords

ADD; ADHD; Anxiety; Attention deficit hyperactivity disorder; Behavioral problems; Homeopathy; Hyperactivity; Impulsivity; Inattention

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; ATOMOXETINE; CALCIUM; DEANOL; ESSENTIAL FATTY ACID; GLYCINE; HYPERICUM PERFORATUM EXTRACT; IRON; LEVACECARNINE; MAGNESIUM; MATRICARIA CHAMOMILLA EXTRACT; MELATONIN; METHYLPHENIDATE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLACEBO; PROBIOTIC AGENT; PYCNOGENOL; PYRIDOXINE; RHODIOLA ROSEA EXTRACT; S ADENOSYLMETHIONINE; TAURINE; THEANINE; TYROSINE; UNINDEXED DRUG; ZINC SULFATE; PLANT MEDICINAL PRODUCT;

ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASE; DECREASED APPETITE; DIET SUPPLEMENTATION; DIET THERAPY; ESSENTIAL FATTY ACID DEFICIENCY; FATIGUE; FOOD ALLERGY; HEADACHE; HERBAL MEDICINE; HOMEOPATHY; HUMAN; INSOMNIA; KINESIOTHERAPY; MINERAL DEFICIENCY; NAUSEA; NONHUMAN; PATHOGENESIS; PROTEIN RESTRICTION; PSYCHOSIS; REVIEW; RISK FACTOR; SUICIDE ATTEMPT; XEROSTOMIA; CHILD; PHYTOTHERAPY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMPLEMENTARY THERAPIES; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; RISK FACTORS;

EID: 84857410305     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (134)

1. Mosby's Medical Dictionary. 8th ed. Philadelphia, PA: Elsevier; 2009.
2. American Psychiatric Association Staff. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:xxi-xxii.
3. Beers MH, Porter RS, Jones TV, et al. (Ed). The Merck Manual of Diagnosis and Therapy. 18th ed. New York, NY: Merck Research Laboratories; 2006:2483-2486.
4. Sadiq AJ. Attention-deficit/hyperactivity disorder and integrative approaches. Pediatr Ann 2007;36:508-515. (Pubitemid 47461777)
5. Truter I. Methylphenidate: prescribing patterns in a South African primary care patient population. J Clin Pharm Ther 2005;30:59-63. (Pubitemid 41602092)
6. Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences / Clinical Psychiatry. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
7. Rader R, McCauley L, Callen EC. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. Am Fam Physician 2009;79:657-665.
8. Harding KL, Judah RD, Gant C. Outcome-based comparison of Ritalin® versus food-supplement treated children with AD/HD. Altern Med Rev 2003;8:319-330. (Pubitemid 37099890)
9. Balch PA. Prescription for Nutritional Healing. 4th ed. New York, NY: Avery, Penguin Group (USA) Inc; 2006:60, 229-232, 355.
10. Sue D, Sue DW, Sue S. Understanding Abnormal Behaviour. 7th ed. New York, NY: Houghton Mifflin Co; 2003.
11. Dvoráková M, Jezová D, Blazícek P, et al. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Nutr Neurosci 2007;10:151-157. (Pubitemid 47490014)
12. Furman L. ADHD: what do we really know? In: Timimi S, Jonathan L, eds. Rethinking ADHD: From Brain to Culture. New York, NY: Palgrave Macmillan; 2009:21-57.
13. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attentiondeficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921.
14. Garrett B. Brain and Behaviour: An Introduction to Biological Psychology. 2nd ed. Los Angeles, CA: SAGE Publications; 2009.
15. Perlov E, Philipsen A, Hesslinger B, et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder - a magnet resonance spectroscopy study. J Psychiatr Res 2007;41:934-941. (Pubitemid 47259094)
16. Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:11-17. (Pubitemid 46452078)
17. Thapar A, Langley K, Owen MJ, O'Donovan MC. Advances in genetic findings on attention deficit hyperactivity disorder. Psychol Med 2007;37:1681-1692. (Pubitemid 350100436)
18. Nigg JT. What Causes ADHD? New York, NY: The Guilford Press; 2006.
19. Dufault R, Schnoll R, Lukiw WJ, et al. Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children. Behav Brain Funct 2009;5:44.
20. Pelsser LM, Buitelaar JK, Savelkoul HF. ADHD as a (non) allergic hypersensitivity disorder: a hypothesis. Pediatr Allergy Immunol 2009;20:107-112.
21. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo controlled trial. Lancet 2001;357:1076-1079. (Pubitemid 32322538)
22. Barrett JR. Diet & nutrition: hyperactive ingredients? Environ Health Perspect 2007;115:A578.
23. McCann D, Barrett A, Cooper A, et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 2007;370:1560-1567. (Pubitemid 350018874)
24. Stevenson J, Sonuga-Barke E, McCann D, et al. The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children's ADHD symptoms. Am J Psychiatry 2010;167:1108-1115.
25. Feller SE, Taylor ATS. Phospholipids. Chemistry Explained. http://www. chemistryexplained.com/Ny-Pi/Phospholipids.html [Accessed August 5, 2010]
26. Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J 2008;7:8.
27. Holford P, Colson D. Optimum Nutrition for Your Child's Mind - Maximize Your Child's Potential. London, UK: Piatkus Books Ltd; 2006.
28. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003;48:195-203. (Pubitemid 36603376)
29. Young GS, Conquer JA, Thomas R. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev 2005;45:549-558. (Pubitemid 41511881)
30. Antalis CJ, Stevens LJ, Campbell M, et al. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2006;75(4-5):299-308. (Pubitemid 44442911)
31. Bornstein RA, Baker GB, Carroll A, et al. Plasma amino acids in attention deficit disorder. Psychiatry Res 1990;33:301-306. (Pubitemid 20299764)
32. Zavala M, Castejon HV, Ortega PA, et al. Imbalance of plasma amino acids in patients with autism and subjects with attention deficit/hyperactivity disorder. Rev Neurol 2001;33:401-408. [Article in Spanish]
33. Wender EH, Solanto MV. Effects of sugar on aggressive and inattentive behavior in children with attention deficit disorder with hyperactivity and normal children. Pediatrics 1991;88:960-966.
34. Langseth L, Dowd J. Glucose tolerance and hyperkinesis. Food Cosmet Toxicol 1978;16:129-133. (Pubitemid 8386565)
35. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50:333-340. (Pubitemid 23143122)
36. Ernst M, Cohen RM, Liebenauer LL, et al. Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36:1399-1406. (Pubitemid 27426251)
37. Girardi NL, Shaywitz SE, Shaywitz BA, et al. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatr Res 1995;38:539-542.
38. Viktorinova A, Trebaticka J, Paduchova Z, et al. Natural polyphenols modify trace element status and improve clinical symptoms of attention-deficit hyperactivity disorder. Biomed Pharmacother 2009 Oct 20 [Epub ahead of print]
39. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. Deficiency of certain trace elements in children with hyperactivity. Psychiatr Pol 1994;28:345-353. [Article in Polish] (Pubitemid 24234918)
40. Kozielec T, Starobrat-Hermelin B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res 1997;10:143-148.
41. Starobrat-Hermelin B. The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders. Ann Acad Med Stetin 1998;44:297-314. [Article in Polish]
42. Oner O, Oner P, Bozkurt OH, et al. Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder. Child Psychiatry Hum Dev 2010;41:441-447.
43. Pizzorno JE, Murray MT, Joiner-Bey H. The Clinician's Handbook of Natural Medicine. London, UK: Churchill Livingstone; 2002.
44. Eubig PA, Aguiar A, Schantz SL. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect 2010;118:1654-1667.
45. Cheuk DK, Wong V. Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in Chinese children. Neuropediatrics 2006;37:234-240. (Pubitemid 46092371)
46. Dubovický M, Kovačovský P, Ujházy E, et al. Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral development. Interdiscip Toxicol 2008;1:206-210.
47. Langley K, Rice F, van den Bree MB, Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr 2005;57:359-371. (Pubitemid 44251940)
48. Patel K, Curtis LT. A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: a prepilot study. J Altern Complement Med 2007;13:1091-1097.
49. Christakis DA, Zimmerman FJ, DiGiuseppe DL, McCarty CA. Early television exposure and subsequent attentional problems in children. Pediatrics 2004;113:708-713. (Pubitemid 38437372)
50. Landhuis CE, Poulton R, Welch D, Hancox RJ. Does childhood television viewing lead to attention problems in adolescence? Results from a prospective longitudinal study. Pediatrics 2007;120:532-537. (Pubitemid 47358296)
51. DeGrandpre R. Ritalin Nation: Rapid-Fire Culture and the Transformation of Human Consciousness. New York, NY: W.W. Norton & Co; 2000.
52. Divan HA, Kheifets L, Obel C, Olsen J. Prenatal and postnatal exposure to cell phone use and behavioral problems in children. Epidemiology 2008;19:523-529.
53. Ott J. Health and Light. New York, NY: Pocket Books; 1973.
54. Painter M. Fluorescent lights and hyperactivity in children: an experiment. Acad Ther 1976;12:181-184.
55. H.E.S.E. Project. Artificial Light in the Environment: Human Health Effects. http://www.hese-project.org/hese-uk/en/issues/cfl.php [Accessed September 16, 2010]
56. Kuo FE, Taylor AF. A potential natural treatment for attention-deficit/ hyperactivity disorder: evidence from a national study. Am J Public Health 2004;94:1580-1586. (Pubitemid 39121598)
57. DuPaul G, Weyandt L. School-based interventions for children and adolescence with attention-deficit/hyperactivity disorder: enhancing academic and behavioral outcomes. Educ Treat Children 2006;29:341-358. (Pubitemid 44553985)
58. Kranowitz CS. The Out-of-Sync Child: Recognizing and Coping with Sensory Processing Disorder. New York, NY: Penguin Group; 2005.
59. Wilens TE. New advances in the psychopharmacological treatment of attention-deficit/hyperactivity disorder. Am Acad Child Adolesc Psychiatry 2008. http://www.aacap.org/cs/root/ developmentor/new-advances-in-the- psychopharmacological-treatment-of-attentiondeficit/hyperactivity-disorder [Accessed July 31, 2008]
60. Barkley R. Take Charge of ADHD: The Complete Authoritative Guide for Parents. Victoria, Australia: Hinkler Books; 2005:323, 327.
61. Huynh H, Luk SL, Singh R, et al. Medium-term outcome of children given stimulants for attention deficit hyperactivity disorder. Child Psychol Psychiatry Review 1999;4:61-67.
62. Balch JF, Stengler M, Young Balch R. Prescription for Drug Alternatives. Hoboken, NJ: John Wiley & Sons, Inc.; 2008;93-104, 161-171.
63. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: Guilford Press; 1998.
64. National Institute of Mental Health (NIMH). Brain Changes Mirror Symptoms in ADHD. 2006. http:www.nimh.nih. gov/science-news/2006/brain-changes-mirror- symptoms-in-adhd.shtml [Accessed 4 April 2008]
65. Aschenbrenner D. Strattera: a new black box warning. Am J Nurs 2006;106:33.
66. Julian RM. A Primer of Drug Action.10th ed. New York, NY: Worth; 2009.
67. Chang HH, Chang CS, Shih YL. The process of assisting behavior modification in a child with attention-deficit hyperactivity disorder. J Nurs Res 2007;15:147-155.
68. Wiles NJ, Northstone K, Emmett P, Lewis G. 'Junk food' diet and childhood behavioural problems: results from the ALSPAC cohort. Eur J Clin Nutr 2009;63:491-498.
69. Pelsser LM, Frankena K, Toorman J, et al. A randomised controlled trial into the effects of food on ADHD. Eur Child Adolesc Psychiatry 2009;18:12-19.
70. Sattelmair J, Ratey JJ. Physically Active Play and Cognition. An Academic Matter? Am J Play 2009;1;365-374. http://www.journalofplay.org/issues/27/62- physically-active-play-and-cognition
71. Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med 2008;14:79-85. (Pubitemid 351185434)
72. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids in ADHD-related symptoms in children with specific learning disabilities. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:233-239. (Pubitemid 34038049)
73. Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 2003;38:1007-1021. (Pubitemid 37444624)
74. Coleman M, Steinberg G, Tippet J, et al. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: a double-blind crossover comparison with methylphenidate. Biol Psychiatry 1979;14:741-751. (Pubitemid 10196853)
75. Mousain-Bosc M, Roche M, Polge A, et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnes Res 2006;19:46-52. (Pubitemid 43945610)
76. Bilici M, Yildirim F, Kandil S, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:181-190. (Pubitemid 37548510)
77. Adriani W, Rea M, Baviera M, et al. Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology (Berl) 2004;176:296-304. (Pubitemid 40012736)
78. Sahley BJ. ADD & ADHD. Natural Control of ADD & ADHD. http://intelegen.com/nutrients/add.htm [Accessed September 10, 2010]
79. Juneja LR, Chu D, Okubo T, et al. L-theanine - a unique amino acid of green tea and its relaxation effect in humans. Trends Food Sci Technol 1999;10:199-204.
80. Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr 2008;17:167-168.
81. Wood DR, Reimherr FW, Wender PH. Amino acid precursors for the treatment of attention deficit disorder, residual type. Psychopharmacol Bull 1985;21:146-149. (Pubitemid 15010896)
82. McConnell H. Catecholamine metabolism in the attention deficit disorder: implications for the use of amino acid precursor therapy. Med Hypotheses 1985;17:305-311. (Pubitemid 15021965)
83. Posner J, Gorman D, Nagel BJ. Tyrosine supplements for ADHD symptoms with comorbid phenylketonuria. J Neuropsychiatry Clin Neurosci 2009;21:228-230.
84. Braun L, Cohen M. Herbs and Natural Supplements: An Evidence-Based Guide. 3rd ed. Chatswood, NSW, Australia: Churchill Livingstone; 2010.
85. Shekim WO, Antun F, Hanna GL, et al. S-adenosyl-L-methionine (SAM) in adults with ADHD, RS: preliminary results from an open trial. Psychopharmacol Bull 1990;26:249-253. (Pubitemid 20291887)
86. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 2002:76:1158S-1161S. (Pubitemid 35244695)
87. Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther 1975;17:534-540.
88. Holford P. Alzheimer's and dementia: the nutrition connection. Prim Care Ment Health 2004;2:5-12.
89. Jäger R, Purpura M, Kingsley M. Phospholipids and sports performance. J Int Soc Sports Nutr 2007;4:5. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC1997116/ [Accessed November 23, 2011]
90. Kidd PM. Phosphatidylserine: The Nutrient that Accelerates all Brain Functions and Counters Alzheimer's Disease. New York, NY: McGraw-Hill; 1998.
91. Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano) 1993;5:123-133. (Pubitemid 23148315)
92. Funfgeld EW, Baggen M, Nedwidek P, et al. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT). Prog Clin Biol Res 1989;317:1235-1246.
93. Manor I, Magen A, Keidar D, et al. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry 2011 Jul 30 [Epub ahead of print]
94. Bendz LM, Scates AC. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother 2010;44:185-191.
95. Weiss MD, Wasdell MB, Bomben MM, et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006;45:512-519.
96. Dvoráková M, Sivonová M, Trebatická J, et al. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep 2006;11:163-172. (Pubitemid 44445647)
97. Chovanová Z, Muchová J, Sivonová M, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res 2006;40:1003-1010. (Pubitemid 44480565)
98. Trebatická J, Kopasová S, Hradecná Z, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Eur Child Adolesc Psychiatry 2006;15:329-335. (Pubitemid 44306140)
99. Shaw W, Kassen E, Chaves E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem 1995;41:1094-1104.
100. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010;17:481-493.
101. Chen QG, Zeng YS, Qu ZQ, et al. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine 2009;16:830-838.
102. Hillhouse B, Dong Sheng M, French C, Towers N. Acetylcholine esterase inhibitors in Rhodiola rosea. Pharm Biol 2004;42:68-72. (Pubitemid 39564226)
103. Ulbricht C, Chao W, Tanguay-Colucci S. Rhodiola (Rhodiola spp.): An evidence-based systematic review by the Natural Standard Research Collaboration. Altern Complement Ther 2011;17:110-119.
104. Olsson EM, von Scheele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract Shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009;75:105-112.
105. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med 2008;14:175-180. (Pubitemid 351364412)
106. Darbinyan V, Aslanyan G, Amroyan E, et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 2007;61:343-348. (Pubitemid 350091013)
107. van Diermen D, Marston A, Bravo J, et al. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol 2009;122:397-401.
108. Bone K. A Clinical Guide to Blending Liquid Herbs. St. Louis, MO: Churchill Livingstone; 2003:137-141, 232-239, 420-427.
109. Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Edinburgh, Scotland: Churchill Livingstone; 2000.
110. Niederhofer H. St. John's wort may improve some symptoms of attention-deficit hyperactivity disorder. Nat Prod Res 2010;24:203-205.
111. Grieve M. A Modern Herbal: Valerian. 2003. http://botanical.com/ botanical/mgmh/v/valeri01.html [Accessed March 24, 2010]
112. Hobbs C. Valerian: The Relaxing and Sleep Herb. Redondo Beach, CA: Botanical Press; 1993:6, 20.
113. Berdonces JL. Attention deficit and infantile hyperactivity. Rev Enferm 2001;24:11-14. [Article in Spanish]
114. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council; 1998.
115. Kemper KJ. Valerian (Valeriana officinalis). The Longwood Herbal Taskforce and The Center for Holistic Pediatric Education and Research. 1999. http://www.longwoodherbal.org/valerian/valerian.pdf [Accessed April 14, 2010]
116. Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine 2010;17:674-678.
117. Chan E, Gardiner P, Kemper K. "At least it's natural...." Herbs and dietary supplements in ADHD. Contemp Pediatr 2000;9:116.
118. Russo A, Borelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 2005;12:305-317. (Pubitemid 40471030)
119. Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001;156:481-484. (Pubitemid 32695859)
120. Negi KS, Singh YD, Kushwaha KP, et al. Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder. Indian J Psychiatry 2000;42:42-50.
121. Pravina K, Ravindra KR, Goudar KS, et al. Safety evaluation of BacoMind in healthy volunteers: a phase I study. Phytomedicine 2007;14:301-308. (Pubitemid 46654793)
122. Frei H, Everts R, von Ammon K, et al. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial. Homeopathy 2007;96:35-41. (Pubitemid 46080721)
123. Bloch R, Lewis B. Homoeopathy for the Home. Cape Town, South Africa: Struik Publishers; 2003.
124. Reichenberg-Ullman J, Ullman R. Ritalin Free Kids: Safe and Effective Homeopathic Medicine for ADHD and Other Behavioral and Learning Problems. Roseville, CA: Prima Health; 2000.
125. Frei H, von Ammon K, Thurneysen A. Treatment of hyperactive children: increased efficiency through modifications of homeopathic diagnostic procedure. Homeopathy 2006;95:163-170. (Pubitemid 43947726)
126. Eizayaga FX. Treatise on Homoeopathic Medicine. Buenos Aires, Argentina: Ediciones Marecel; 1991.
127. Lange A. Getting at the Root: Treating the Deepest Source of Disease. Berkeley, CA: North Atlantic Books; 2002.
128. Strauss LC. The Efficacy of Selenium Homaccord in the Management of Attention Deficit Hyperactivity Disorder. Unpublished thesis. Johannesburg, South Africa: University of Johannesburg; 1998.
129. Smith L, Blanche MJ, Solomon EM. The Effect of Cerbo® and Nerva 2® on Attention Deficit Hyperactivity Disorder. Unpublished thesis. Johannesburg, South Africa: University of Johannesburg; 2001.
130. White SJ, Roohani J, Henn C. The Efficacy of Valeriana officinalis Mother Tincture and Valeriana Officinala 3x in the Treatment of Attention Deficit Hyperactivity Disorder. Unpublished thesis. Johannesburg, South Africa: University of Johannesburg; 2004.
131. Lamont J. Homoeopathic treatment of attention deficit hyperactivity disorder. Br Homeopath J 1997;86:196-200.
132. Barnard CN, Solomon EM, Pellow J. The Efficacy of the Homeopathic Simillimum in LM Potency in the Treatment of Children with Attention-Deficit/ Hyperactivity Disorder (ADHD). Unpublished thesis. Johannesburg, South Africa: University of Johannesburg; 2010.
133. Frei H, Thurneysen A. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting. Br Homeopath J 2001;90:183-188.
134. Frei H, Everts R, von Ammon K, et al. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr 2005;164:758-767. (Pubitemid 41609477)